3152 related articles for article (PubMed ID: 17021169)
1. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
Oakley H; Cole SL; Logan S; Maus E; Shao P; Craft J; Guillozet-Bongaarts A; Ohno M; Disterhoft J; Van Eldik L; Berry R; Vassar R
J Neurosci; 2006 Oct; 26(40):10129-40. PubMed ID: 17021169
[TBL] [Abstract][Full Text] [Related]
2. Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation.
Eimer WA; Vassar R
Mol Neurodegener; 2013 Jan; 8():2. PubMed ID: 23316765
[TBL] [Abstract][Full Text] [Related]
3. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
[TBL] [Abstract][Full Text] [Related]
4. Presenilin transgenic mice as models of Alzheimer's disease.
Elder GA; Gama Sosa MA; De Gasperi R; Dickstein DL; Hof PR
Brain Struct Funct; 2010 Mar; 214(2-3):127-43. PubMed ID: 19921519
[TBL] [Abstract][Full Text] [Related]
5. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
6. Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody.
Youmans KL; Tai LM; Kanekiyo T; Stine WB; Michon SC; Nwabuisi-Heath E; Manelli AM; Fu Y; Riordan S; Eimer WA; Binder L; Bu G; Yu C; Hartley DM; LaDu MJ
Mol Neurodegener; 2012 Mar; 7():8. PubMed ID: 22423893
[TBL] [Abstract][Full Text] [Related]
7. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
Sadleir KR; Eimer WA; Cole SL; Vassar R
Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526
[TBL] [Abstract][Full Text] [Related]
8. Intraneuronal Aβ accumulation, amyloid plaques, and synapse pathology in Alzheimer's disease.
Capetillo-Zarate E; Gracia L; Tampellini D; Gouras GK
Neurodegener Dis; 2012; 10(1-4):56-9. PubMed ID: 22269167
[TBL] [Abstract][Full Text] [Related]
9. Alteration of cortical EEG in mice carrying mutated human APP transgene.
Wang J; Ikonen S; Gurevicius K; van Groen T; Tanila H
Brain Res; 2002 Jul; 943(2):181-90. PubMed ID: 12101040
[TBL] [Abstract][Full Text] [Related]
10. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease.
Kukreja L; Kujoth GC; Prolla TA; Van Leuven F; Vassar R
Mol Neurodegener; 2014 May; 9():16. PubMed ID: 24885175
[TBL] [Abstract][Full Text] [Related]
11. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
[TBL] [Abstract][Full Text] [Related]
12. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.
Oddo S; Caccamo A; Shepherd JD; Murphy MP; Golde TE; Kayed R; Metherate R; Mattson MP; Akbari Y; LaFerla FM
Neuron; 2003 Jul; 39(3):409-21. PubMed ID: 12895417
[TBL] [Abstract][Full Text] [Related]
13. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
14. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
[TBL] [Abstract][Full Text] [Related]
15. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.
Mucke L; Masliah E; Yu GQ; Mallory M; Rockenstein EM; Tatsuno G; Hu K; Kholodenko D; Johnson-Wood K; McConlogue L
J Neurosci; 2000 Jun; 20(11):4050-8. PubMed ID: 10818140
[TBL] [Abstract][Full Text] [Related]
16. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
Crews L; Rockenstein E; Masliah E
Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
[TBL] [Abstract][Full Text] [Related]
17. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.
Casas C; Sergeant N; Itier JM; Blanchard V; Wirths O; van der Kolk N; Vingtdeux V; van de Steeg E; Ret G; Canton T; Drobecq H; Clark A; Bonici B; Delacourte A; Benavides J; Schmitz C; Tremp G; Bayer TA; Benoit P; Pradier L
Am J Pathol; 2004 Oct; 165(4):1289-300. PubMed ID: 15466394
[TBL] [Abstract][Full Text] [Related]
18. Mouse models of Alzheimer's disease: insight into treatment.
German DC; Eisch AJ
Rev Neurosci; 2004; 15(5):353-69. PubMed ID: 15575491
[TBL] [Abstract][Full Text] [Related]
19. Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention.
Agca C; Klakotskaia D; Schachtman TR; Chan AW; Lah JJ; Agca Y
BMC Neurosci; 2016 Jul; 17(1):46. PubMed ID: 27388605
[TBL] [Abstract][Full Text] [Related]
20. A pathogenic presenilin-1 deletion causes abberrant Abeta 42 production in the absence of congophilic amyloid plaques.
Steiner H; Revesz T; Neumann M; Romig H; Grim MG; Pesold B; Kretzschmar HA; Hardy J; Holton JL; Baumeister R; Houlden H; Haass C
J Biol Chem; 2001 Mar; 276(10):7233-9. PubMed ID: 11084029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]